2017

Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A.
Giangrande P1, Andreeva T, Chowdary P, Ehrenforth S, Hanabusa H, Leebeek FW, Lentz SR, Nemes L, Poulsen LH, Santagostino E, You CW, Clausen WH, Jönsson PG, Oldenburg J; Pathfinder™2 Investigators.
Thromb Haemost. 2017 Jan 26;117(2):252-261. doi: 10.1160/TH16-06-0444. Epub 2016 Dec 1.


2016

Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm™4).
Young G1, Collins PW2, Colberg T3, Chuansumrit A4, Hanabusa H5, Lentz SR6, Mahlangu J7, Mauser-Bunschoten EP8, Négrier C9, Oldenburg J10, Patiroglu T11, Santagostino E12, Tehranchi R3, Zak M3, Karim FA13.
Thromb Res. 2016 May;141:69-76. doi: 10.1016/j.thromres.2016.02.030. Epub 2016 Mar 2.

Protein methionine oxidation augments reperfusion injury in acute ischemic stroke.
Gu SX1, Blokhin IO1, Wilson KM1, Dhanesha N1, Doddapattar P1, Grumbach IM1, Chauhan AK1, Lentz SR1.
JCI Insight.
2016;1(7). pii: e86460. Epub 2016 May 19.

Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery.
Buckner TW1, Leavitt AD, Ragni M, Kempton CL, Eyster ME, Cuker A, Lentz SR, Ducore J, Leissinger C, Wang M, Key NS.
Thromb Haemost. 2016 Jul 4;116(1):42-9. doi: 10.1160/TH15-10-0802. Epub 2016 Mar 24.